​
​

Hepion Pharmaceuticals Ownership | Who Owns Hepion Pharmaceuticals?

OverviewForecastRevenueFinancialsChart

Hepion Pharmaceuticals Ownership Summary

Hepion Pharmaceuticals is owned by 9.38% institutional investors, and 90.62% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.84% of its assets in Hepion Pharmaceuticals shares.

HEPA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockHepion Pharmaceuticals9.38%-90.62%
SectorHealthcare Stocks 47.38%7.99%44.63%
IndustryBiotech Stocks 45.43%7.81%46.75%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202330-7,152,5150.18%910.70%12-20.00%6-25.00%
Dec 31, 2022307.14%7,139,728-0.11%910.65%1566.67%833.33%
Sep 30, 202228-6.67%7,147,914-3.40%99.95%912.50%6-45.45%
Jun 30, 202230-18.92%7,399,330-2.00%99.89%8-50.00%1137.50%
Mar 31, 202237-11.90%7,549,956-4.32%99.24%16-15.79%8-20.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr48.91K0.84%-
Vanguard Total Stock Mkt Idx Inv40.67K0.70%-12.49K
Fidelity Extended Market Index32.59K0.56%4.19K
BlackRock Extended Equity Market K12.68K0.22%-5.00
Fidelity Series Total Market Index5.45K0.09%-
Fidelity Total Market Index5.27K0.09%-
Vifag 2002 SICAV5.00K0.09%-
NT Ext Equity Mkt Idx Fd - NL3.68K0.06%-
Northern Trust Extended Eq Market Idx3.23K0.06%-
NT Ext Equity Mkt Idx Fd - L3.23K0.06%-

Recent Insider Transactions

DateNameRoleActivityValue
Nov 24, 2023Wijngaard Peter-Buy$7.72K
Nov 27, 2023Wijngaard Peter-Buy$7.63K
Sep 15, 2023Wijngaard Peter-Buy$4.62K
Sep 15, 2023Wijngaard Peter-Buy$757.55
Sep 19, 2023Wijngaard Peter-Buy$5.64K

Insider Transactions Trends

DateBuySell
2024 Q1--
2023 Q42-
2023 Q36-
2022 Q2--
2021 Q2--

HEPA Ownership FAQ

Who Owns Hepion Pharmaceuticals?

Hepion Pharmaceuticals shareholders are primarily institutional investors at 9.38%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Hepion Pharmaceuticals's industry, Biotech Stocks , is 45.43%, which Hepion Pharmaceuticals falls below.

Does Blackrock own Hepion Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Hepion Pharmaceuticals.

Who is the top mutual fund holder of Hepion Pharmaceuticals shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Hepion Pharmaceuticals shares, with 0.84% of its total shares outstanding invested in 48.91K Hepion Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools